Navigation Links
Alzheimer's Pilot Study Proposed for Ustekinumab (Stelara)
Date:6/12/2013

(PRWEB) June 12, 2013

Currently clinical trials are ongoing in the U.S., Nicaragua and U.K. to evaluate the efficacy of the FDA approved psoriasis drug Enbrel as an Alzheimer's treatment.* Similar clinical trials are needed to evaluate the efficacy of the FDA approved psoriasis drug Stelara as an Alzheimer's treatment. Both Enbrel and Stelara work by blocking molecular sub-units of inflammatory protiens. Enbrel targets TNF-alpha, Stelara targets IL-12 and IL-23.

Neurological Recovery Guide and Neurological Wellness Center have been facilitating recovery from Alzheimer's since 2010 by teaching perispinal Enbrel injection technique to physicians and caregivers.

Neurological Wellness Center offers a complete two-hour course on Alzheimer's treatment covering all aspects of perispinal injection technique at their center in Managua Nicaragua.

"Although there is a wide range of outcomes, the observed results and anecdotal reports we have received from physicians and caregivers treating individuals with Alzheimer's with perispinally administered Enbrel, generally confirm the findings of Edward Tobinick M.D," (.ncbi.nlm.nih.gov/pmc/articles/PMC1785182/ ) stated Rolando Hernandez M.D., neurosurgeon for Neurological Wellness Center.

For many, flying to Neurological Wellness Center in Managua Nicaragua to receive this personalized training is an enormous expense and inconvenience. To overcome this problem, Neurological Wellness Center, under the direction of Augusto Ramirez, M.D., created Perispinal Enbrel Step-By-Step Instructional Video and accompanying e-book. This 24-minute video and 37-page e-book are now available online at: neurological-recovery-guide.com.

Augusto Ramirez, M.D., Director of Neurological Wellness Center, a private medical group in Managua Nicaragua, authorized this press release.

Neurological Wellness Center’s perispinal Enbrel is effective as an Alzheimer's treatment, stroke treatment with our stroke clinical trial and as a TBI treatment.

The drug Enbrel is available now. Enbrel received FDA approval in 1998. Its safety profile is well understood. For Enbrel to effectively treat Alzheimer’s, stroke and TBI, it must be administered to the back of the neck precisely between the cervical vertebrae C-5 and C-6. This perispinal injection allows Enbrel to enter the brain by lymph drainage assisted by gravity. Fortunately for the millions of people now afflicted with Alzheimer’s, stroke and TBI, a video is now available online detailing in step-by-step fashion how to administer a perispinal injection of Enbrel,” said Dr. Rolando Hernandez.

To enroll in a hands-on instructional course on perispinal injections visit: reversealzheimersnow.com.

To purchase an instructional video and e-book on administering perispinal injections visit: neurological-recovery-guide.com

*://clinicaltrials.gov/ct2/show/NCT01716637?term=etanercept+AND+brain&rank=1
:prweb.com/releases/2013/5/prweb10603523.htm
://clinicaltrials.gov/show/NCT01068353

Read the full story at http://www.prweb.com/releases/2013/6/prweb10702340.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Two Leading Alzheimer's Disease Researchers Recognized with MetLife Foundation Awards
2. myCNAjobs Delivers Alzheimer's and Memory Caregiver Training Online
3. BMA Affordable Assisted Living Community to Host Educational Program on Alzheimer's Disease
4. Alzheimer's Treatment Clinical Trial Receives Clearance
5. New Study Links Air Pollution to Alzheimer’s Disease -- Says Cure Alzheimer's Fund
6. Life Extension Foundation Seeks Volunteers with Alzheimer's to Participate in a Clinical Trial Utilizing a Common Arthritis Drug
7. Congresswoman Michelle Bachmann Supports Barak Obama's Call to Prioritize Research to "Unlock the Answers to Alzheimer's"
8. Watson, IBM'S Supercomputer is Now Programmed to Recommend Perispinally Administered Etanercept as an Alzheimer's Disease Treatment
9. Goldberg & Goldberg Files Wrongful Death Lawsuit on Behalf of a 91 year-old Alzheimer's Patient Who Froze to Death Outside a Retirement Community
10. A Feinstein Institute for Medical Research Study Shows Early Cognitive Problems among Those Who Eventually Get Alzheimer's
11. Neurological Wellness Center's Novel Neuro-Inflammation Inhibition Procedure that Induces Rapid Recovery from Alzheimer's, Stroke and Brain Injury is Now Being Taught in a Newly Released Video
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... December 09, 2016 , ... MEDI+SIGN®, a provider ... that a new solution for Emergency Departments (ED) has been added to their ... Emergency Department examination rooms, and with a simplified pallet of information available to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... with distinction by the Undersea and Hyperbaric Medical Society (UHMS), the leading authority ... care and patient safety. Only a few hospitals and facilities have earned this ...
(Date:12/8/2016)... ... December 08, 2016 , ... Seavest ... Property owned by an affiliate of Seavest, has won a prestigious national healthcare ... Chester County ambulatory care center (ACC) was named “Best New Development, MOBs and ...
(Date:12/8/2016)... ... December 08, 2016 , ... David J. Dykeman , ... Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont ... and attorneys from the firm’s global Life Sciences & Medical Technology Group have been ...
(Date:12/8/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had joined the Pharmaceutical Supply Chain Initiative (PSCI). ... unite pharmaceutical and healthcare companies that share a vision of better, social, environmental ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 KEY FINDINGS ... the largest share of the market in 2016 and ... dominance can be attributed to a large number of ... (US hold the largest share in the patient temperature ... benefits such as reducing loss of blood during surgeries, ...
(Date:12/8/2016)... 8, 2016 Research and Markets has announced ... Trends - Adhesion Type, Application, Usability - Forecast to 2025" ... , ... Market is poised to grow at a CAGR of around 3.2% ... market is witnessing include advancements in extracellular microelectrode arrays and intracellular ...
(Date:12/8/2016)... Quebec , Dec. 8, 2016  Valeant ... and TSX: VRX) ("Valeant") today announced positive results ... clinical study to assess the safety and efficacy ... the treatment of plaque psoriasis. ... subjects with moderate to severe psoriasis, IDP-118 showed ...
Breaking Medicine Technology: